Clinical Trials
215 trialsNCT06255041 2026-05-15
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
Completed
NCT04122976 2026-05-11
DAROL
Bayer
Active not recruiting
NCT07451002 2026-05-08
OBSAPA
Janssen Cilag S.A.S.
Recruiting
NCT07124000 2026-05-01
DP-04
AstraZeneca
Recruiting
NCT07560215 2026-05-01
PROMET-BR
AstraZeneca
Not yet recruiting
NCT07543757 2026-04-22
PRIME
Sequenom, Inc.
Recruiting
NCT06517719 2026-04-13
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Novartis
Recruiting
NCT07406282 2026-04-09
Double-DARE
Bayer
Recruiting
NCT05467176 2026-04-08
OPTYX
Sumitomo Pharma America, Inc.
Active not recruiting
NCT07344779 2026-04-03
ROAD
Bayer
Active not recruiting
NCT07290270 2026-03-30
PSMAreal
Novartis
Recruiting
NCT07484269 2026-03-20
PULSE
Novartis
Not yet recruiting
NCT07477756 2026-03-19
A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients
Novartis
Completed
NCT07474051 2026-03-16
PERSIST
AvenCell Therapeutics, Inc.
Enrolling by invitation
NCT07454603 2026-03-06
PROSTest_STRAT
Wren Laboratories LLC
Not yet recruiting
NCT07455058 2026-03-06
VAPOR-LTR
Francis Medical Inc.
Not yet recruiting
NCT07450157 2026-03-04
A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617
Novartis
Completed
NCT07432360 2026-02-25
Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology
Virdx, Inc.
Recruiting
NCT07052578 2026-02-24
CONCORD
AstraZeneca
Recruiting
NCT04964271 2026-02-02
Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
Tethis S.p.A.
Active not recruiting
NCT05701007 2026-01-29
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Completed
NCT03516110 2026-01-23
PRISME
Ipsen
Completed
NCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT07318051 2026-01-15
SCORE
Natera, Inc.
Recruiting
NCT06717295 2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
NCT06072196 2025-12-31
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer
Completed
NCT07146113 2025-12-23
PRIME
AstraZeneca
Recruiting
NCT06055946 2025-12-22
BARVANA LONG
Aesculap AG
Completed
NCT04034095 2025-12-15
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
Janssen Pharmaceutical K.K.
Completed
NCT06462014 2025-12-11
Description of Relugolix Use in Patients With Prostate Cancer Within the VHA
Pfizer
Completed
NCT07086651 2025-12-08
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
Pfizer
Completed
NCT06970275 2025-12-05
PETRiS
XEOS Medical
Recruiting
NCT06733337 2025-11-17
A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.
Pfizer
Active not recruiting
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT04560452 2025-10-08
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
AstraZeneca
Completed
NCT05354440 2025-09-19
CLP-10441
BioProtect
Active not recruiting
NCT05323747 2025-09-16
BP-008
BioProtect
Completed
NCT05354427 2025-09-16
CLP-10095
BioProtect
Completed
NCT04580667 2025-08-28
Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity
DiaCarta, Inc.
Withdrawn
NCT06607783 2025-08-28
PREDICT
Gold Standard Phantoms
Not yet recruiting
NCT04553926 2025-08-14
OLAP
AstraZeneca
Completed
NCT05202301 2025-08-11
A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely
Bayer
Completed
NCT04404894 2025-07-14
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
Myriad Genetic Laboratories, Inc.
Active not recruiting
NCT06655064 2025-07-14
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations
Telix Pharmaceuticals (Innovations) Pty Limited
Terminated
NCT06194461 2025-06-27
LOCUS
AstraZeneca
Not yet recruiting
NCT06151418 2025-06-04
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Pfizer
Completed
NCT03957252 2025-05-30
APCaRI-05
Nanostics
Active not recruiting
NCT05735652 2025-05-30
An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel
Boston Scientific Corporation
Completed
NCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT06500741 2025-05-06
Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients
Astellas Pharma Inc
Completed